| MR编号 | NL/H/6030/003 |
|---|
| 药品名称 | Sacubitril/Valsartan Synthon 97 mg/103 mg |
|---|
| 活性成分 | - Sacubitril sodium 97.2 mg
- Valsartan 102.8 mg
|
|---|
| 剂型 | Film-coated tablet |
|---|
| 上市许可持有人 | Accord Healthcare B.V. / NL |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) |
|---|
| 互认成员国 - 产品名称 | - France (FR)
- Italy (IT)
- Sweden (SE)
- Norway (NO)
- Finland (FI)
- Latvia (LV)
- Lithuania (LT)
- Estonia (EE)
- Cyprus (CY)
SACUBITRIL/VALSARTAN ACCORD 97 mg/103 mg film-coated tablets - Germany (DE)
Sacubitril/Valsartan Accord 97 mg/103 mg Filmtabletten - Czechia (CZ)
Sacubitril/Valsartan Accord - Denmark (DK)
Sacubitril/Valsartan Accord - Croatia (HR)
- Ireland (IE)
|
|---|
| 许可日期 | 2025/06/20 |
|---|
| 最近更新日期 | 2025/07/14 |
|---|
| 药物ATC编码 | - C09DX04 valsartan and sacubitril
| 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Additional Strength/Form
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|